Saamya Biotech (India) Limited reported audited standalone earnings results for the fourth quarter and full year ended March 31, 2016. For the quarter, the company reported nil net sales/income from operation against INR 251,007,949 a year ago. Loss from operations before other income, interest & exceptional items was INR 2,681,311 against INR 4,297,868 a year ago. Loss from ordinary activities before tax was INR 2,544,144 against INR 3,969,262 a year ago. Net loss from ordinary activities after tax was INR 2,423,517 or INR 0.10 per basic and diluted share against net loss from ordinary activities after tax INR 3,429,325 or INR 0.14 per basic and diluted share a year ago. For the quarter, the company reported net sales/income from operation of INR 144,021,942 against INR 287,683,992 a year ago. Loss from operations before other income, interest & exceptional items was INR 10,472,701 against INR 7,589,120 a year ago. Loss from ordinary activities before tax was INR 9,379,210 against INR 7,327,832 a year ago. Net loss from ordinary activities after tax was INR 4,411,548 or INR 0.18 per basic and diluted share against net loss from ordinary activities after tax INR 6,787,895 or INR 0.27 per basic and diluted share a year ago.